Oncology

layoffs cut staff reduction workforce
Biotech

Genetic medicines biotech halves team

The workforce reduction will affect 37 employees at the Boston biotech, according to Ensoma CEO Jim Burns, Ph.D.
Gabrielle Masson Nov 20, 2025 10:15am
Assortment of tools laid out on wooden background

Repare nails down XenoTherapeutics buyout

Nov 17, 2025 12:12pm
Clear out clearnance rubbish scrap heap

Bayer bails on Vividion tumor drug in early-stage clear-out

Nov 12, 2025 8:10am
pipeline pipes RD research

Cullinan puts kibosh on 2 cancer assets amid autoimmune refocus

Nov 6, 2025 1:26pm
Novo Nordisk

Novo drops oncology ambitions, early-stage MASH prospects

Nov 5, 2025 7:21am
GSK ESMO

GSK loses hope for CD226 cancer therapies, dropping ph. 2 assets

Oct 29, 2025 6:29am
More News

Cardiometabolic field drives M&A while cancer deals drop: report

Oct 27, 2025 2:39pm

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am

Boehringer digs in on ADCs with $991M AimedBio licensing accord

Oct 15, 2025 10:05am

Tubulis touts $361M series C as next-gen ADC data drop nears

Oct 15, 2025 5:01am